Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-20T01:35:02.224Z Has data issue: false hasContentIssue false
  • English
  • Français

Whole-Blood Interferon-Gamma Release Assay for Baseline Tuberculosis Screening of Healthcare Workers at a Swiss University Hospital

Published online by Cambridge University Press:  02 January 2015

Ariane Stebler ,
Patricia Iseli ,
Kathrin Mühlemann  and
Thomas Bodmer
Ariane Stebler
Affiliation:
Institute for Infectious Diseases, University of Berne, Berne, Switzerland
Patricia Iseli
Affiliation:
Occupational Health Care Service, University Hospital of Berne, Berne, Switzerland
Kathrin Mühlemann
Affiliation:
Institute for Infectious Diseases, University of Berne, Berne, Switzerland
Thomas Bodmer*
Affiliation:
Institute for Infectious Diseases, University of Berne, Berne, Switzerland
*
University of Berne, Institute for Infectious Diseases, Friedbühlstrasse 51, CH-3010 Berne, Switzerland (thomas.bodmer@ifik.unibe.ch)
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 29 , Issue 7 , July 2008 , pp. 681 - 683
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

References

1.World Health Organization. Global TB database. Available at: http://www.who.int./tb/country/en/index.html. Accessed October 2006.Google Scholar
2.American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221–S247.Google Scholar
3.Jensen, PA, Lambert, LA, Iademarco, MF, Ridzon R; Centers for Disease Control. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings. MMWR Morb Mortal Wkly Rep 2005;54:1–141.Google ScholarPubMed
4.Jasmer, RM, Nahid, P, Hopewell, PC. Latent tuberculosis infection. N Engl J Med 2002;347:1860–1866.CrossRefGoogle ScholarPubMed
5.Pai, M, Riley, LW, Colford, JM Jr. Interferon-γ–release assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004;4:761–776.CrossRefGoogle Scholar
6.Cellestis. QuantiFeron-TB Gold In-Tube: technical information; package insert. Accessed January 2008.Google Scholar
7.Nienhaus, A, Schablon, A, Bâde, CL, Siano, B, Diel, R. Evaluation of the interferon-γ–release assay in healthcare workers. Int Arch Occup Environ Health 2008;81:295–300.CrossRefGoogle ScholarPubMed
8.Harada, N, Nakajima, Y, Higuchi, K, Sekiya, Y, Rothel, J, Mori, T. Screening for tuberculosis infection using whole-blood interferon-γ and Mantoux testing among Japanese healthcare workers. Infect Control and Hosp Epidemiol 2006;27:442–448.CrossRefGoogle ScholarPubMed
9.Nienhaus, A, Schablon, A, Loddenkemper, A, Hauer, B, Wolf, N, Diel, R. Prevalence of latent tuberculosis infection in healthcare workers in geriatric care. Pneumologie 2007;61:613–616.CrossRefGoogle ScholarPubMed